Federal officials have approved another generic version of the abortion pill mifepristone, a regulatory formality that quickly triggered pushback from anti-abortion groups and politicians aligned with the Trump administration.

Drugmaker Evita Solutions announced on its website that the Food and Drug Administration signed off on its low-cost form of the pill, which is approved to end pregnancies through 10 weeks. Evita Solutions is the second company to have an approved generic version of mifepristone. The first was from pharmaceutical company GenBioPro, approved in 2019 .

The move prompted backlash from some conservatives.

Republican Sen. Josh Hawley of Missouri criticized the move in a post on X, stating: "I have lost confidence in the leadership at FDA."

"Anyone who tries to say

See Full Page